Adzenys ER (Neos Therapeutics, LP)


Welcome to the PulseAid listing for the Adzenys ER drug offered from Neos Therapeutics, LP. This Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Neos Therapeutics, LP
NON-PROPRIETARY NAME: Amphetamine
SUBSTANCE NAME: AMPHETAMINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE]
ROUTE: ORAL
DOSAGE FORM: SUSPENSION, EXTENDED RELEASE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2017-09-16
END MARKETING DATE: 0000-00-00


Adzenys ER HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAdzenys ER from Neos Therapeutics, LP
LABELER NAME: Neos Therapeutics, LP
DEA SCHEDULE: CII
ACTIVE STRENGTH: 1.25(mg/mL)
START MARKETING DATE: 2017-09-16
END MARKETING DATE: 0000-00-00
PRODUCT ID: 70165-003_8e3677f7-b759-4a96-b064-2382a74c4af1
PRODUCT NDC: 70165-003
APPLICATION NUMBER: NDA204325

Other AMPHETAMINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Neos Therapeutics, LPAdzenys ER
Tris Pharma IncDyanavel XR